1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Clinical and histologic data of patients with positive and negative findings on MRI
Negative MRI Findings Positive MRI Findings Total No. of patients 29 42 71 Sex ratio (M/F) 0.8 1.8 1.3 Age at onset (yr) (median) (range) 6 (1–20) 5.8 (1–20) 6 (1–20) Age at surgery (yr) (median) (range) 17 (8–41) 22.5 (8–52) 20 (8–52) Location of FCD Left/right ratio 1.4 1.25 1.35 Frontal lobe 23 37 60 Parietal lobe 4 3 7 Temporal lobe 1 1 2 Occipital lobe 1 1 2 Type 2 FCD subtypes Type 2a (no balloon cells) 6 2 8 Type 2b (balloon cells) 23 40 63